Tuesday, February 21, 10 to 11:30 a.m., In-person, President's Dining Room #113, Bernhard Center, WMU Main Campus Are you a graduate student who is preparing for an upcoming research poster ...
Poster hang up: 9:30 a.m. - 10:00 a.m. Poster presentations: 10 a.m. - 12 p.m. Poster judging: 10 a.m. - 11 a.m. Awards presentation: 12:15 p.m. - 12:45 p.m. The ...
BOSTON, Oct. 23, 2024 /PRNewswire/ -- Nemdx, Inc. today announced a poster presentation at the 2024 Northeast ALS Annual Conference (NEALS) hosted online on October 21-24. The poster, presented by ...
CHICAGO--(BUSINESS WIRE)-- MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today ...
A clinical pharmacist from Monmouth Medical Center, Southern Campus recently represented Barnabas Health at the AC Forum's 13th National Conference on Anticoagulant Therapy in Washington, D.C. on ...
ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Equillium Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback